NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vaxart Inc (NASDAQ: VXRT)

 
VXRT Technical Analysis
5
As on 9th Jun 2023 VXRT STOCK Price closed @ 0.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.78 & Strong Sell for SHORT-TERM with Stoploss of 5.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VXRTSTOCK Price

Open 0.89 Change Price %
High 0.91 1 Day -0.05 -5.56
Low 0.83 1 Week -0.37 -30.33
Close 0.85 1 Month 0.08 10.39
Volume 4053608 1 Year -6.11 -87.79
52 Week High 7.52 | 52 Week Low 0.60
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VXRT
Daily Charts
VXRT
Intraday Charts
Whats New @
Bazaartrend
VXRT
Free Analysis
 
VXRT Important Levels Intraday
RESISTANCE1.00
RESISTANCE0.95
RESISTANCE0.92
RESISTANCE0.89
SUPPORT0.81
SUPPORT0.78
SUPPORT0.75
SUPPORT0.70
 
VXRT Forecast May 2024
4th UP Forecast5.21
3rd UP Forecast3.81
2nd UP Forecast2.95
1st UP Forecast2.08
1st DOWN Forecast-0.38
2nd DOWN Forecast-1.25
3rd DOWN Forecast-2.11
4th DOWN Forecast-3.51
 
VXRT Weekly Forecast
4th UP Forecast2.49
3rd UP Forecast1.96
2nd UP Forecast1.64
1st UP Forecast1.31
1st DOWN Forecast0.39
2nd DOWN Forecast0.06
3rd DOWN Forecast-0.26
4th DOWN Forecast-0.79
 
VXRT Forecast2024
4th UP Forecast13.45
3rd UP Forecast9.41
2nd UP Forecast6.91
1st UP Forecast4.41
1st DOWN Forecast-2.71
2nd DOWN Forecast-5.21
3rd DOWN Forecast-7.71
4th DOWN Forecast-11.75
 
 
VXRT Other Details
Segment EQ
Market Capital 841821120.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VXRT Address
VXRT
 
VXRT Latest News
 
Your Comments and Response on Vaxart Inc
 
VXRT Business Profile
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which completed Phase I clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The company is headquartered in South San Francisco, California. Address: 170 Harbor Way, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service